Legend Biotech's market cap is currently $7.01B. The company's EPS TTM is $-1.907; its P/E ratio is ―; Legend Biotech is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 285.14M	$ 117.00M	$ 89.79M	$ 75.68M	$ 57.26M
Gross Profit	$ 140.93M	$ 51.64M	$ -223.55M	$ -156.48M	$ 57.26M
Operating Income	$ -439.49M	$ -455.83M	$ -393.02M	$ -313.35M	$ -130.87M
EBITDA	$ -477.87M	$ -416.54M	$ -392.38M	$ -294.14M	$ -124.89M
Net Income	$ -518.25M	$ -446.35M	$ -386.21M	$ -303.48M	$ -132.97M
Balance Sheet
Cash & Short-Term Investments	$ 1.31B	$ 1.03B	$ 882.39M	$ 505.69M	$ 158.92M
Total Assets	$ 1.85B	$ 1.33B	$ 1.12B	$ 721.01M	$ 287.71M
Total Debt	$ 328.67M	$ 284.53M	$ 122.97M	$ 3.37M	$ 6.08M
Net Debt	$ -949.04M	$ -501.50M	$ -565.97M	$ -452.32M	$ -77.28M
Total Liabilities	$ 597.24M	$ 586.65M	$ 647.16M	$ 440.75M	$ 410.58M
Stockholders' Equity	$ 1.25B	$ 744.31M	$ 471.21M	$ 280.25M	$ -122.87M
Cash Flow
Free Cash Flow	$ -416.00M	$ -222.30M	$ -245.58M	$ -272.78M	$ -122.23M
Operating Cash Flow	$ -393.28M	$ -200.03M	$ -198.47M	$ -223.00M	$ -83.06M
Investing Cash Flow	$ 92.79M	$ -78.34M	$ -194.98M	$ -24.17M	$ -58.65M
Financing Cash Flow	$ 791.49M	$ 377.98M	$ 626.66M	$ 618.88M	$ 14.67M

Currency in USD

Legend Biotech Earnings and Revenue History

Income Statement >

Legend Biotech Debt to Assets

Balance Sheet >

Legend Biotech Cash Flow

Cash Flow >

Legend Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing